Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Environmental Exposure | 23 | 2024 | 4412 | 2.890 |
Why?
|
Nutrition Surveys | 28 | 2024 | 1725 | 2.750 |
Why?
|
Drug Repositioning | 6 | 2018 | 232 | 2.570 |
Why?
|
Metagenomics | 5 | 2023 | 457 | 1.820 |
Why?
|
Computational Biology | 13 | 2024 | 3505 | 1.690 |
Why?
|
Metagenome | 4 | 2023 | 450 | 1.370 |
Why?
|
Disease | 6 | 2019 | 671 | 1.370 |
Why?
|
Environmental Pollutants | 8 | 2024 | 1266 | 1.360 |
Why?
|
Diabetes Mellitus, Type 2 | 15 | 2024 | 12293 | 1.160 |
Why?
|
Environmental Health | 6 | 2021 | 284 | 1.110 |
Why?
|
Endocrine Disruptors | 2 | 2021 | 263 | 1.090 |
Why?
|
Toxicogenetics | 3 | 2016 | 20 | 1.000 |
Why?
|
Prediabetic State | 2 | 2021 | 550 | 0.990 |
Why?
|
Databases, Factual | 11 | 2019 | 8035 | 0.930 |
Why?
|
Epidemiologic Research Design | 3 | 2020 | 368 | 0.910 |
Why?
|
Biological Specimen Banks | 3 | 2024 | 783 | 0.900 |
Why?
|
Software | 10 | 2024 | 4419 | 0.890 |
Why?
|
Government | 1 | 2024 | 160 | 0.870 |
Why?
|
Extreme Heat | 1 | 2023 | 57 | 0.840 |
Why?
|
Genetic Predisposition to Disease | 13 | 2024 | 17790 | 0.720 |
Why?
|
Models, Statistical | 6 | 2021 | 5075 | 0.710 |
Why?
|
Genome, Human | 5 | 2018 | 4417 | 0.710 |
Why?
|
Blood Glucose | 6 | 2024 | 6381 | 0.690 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12626 | 0.670 |
Why?
|
Semen Analysis | 2 | 2018 | 234 | 0.670 |
Why?
|
Genetic Association Studies | 7 | 2024 | 2717 | 0.650 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 3224 | 0.620 |
Why?
|
Disease Transmission, Infectious | 1 | 2024 | 558 | 0.610 |
Why?
|
Phenotype | 16 | 2024 | 16546 | 0.590 |
Why?
|
Genetic Variation | 10 | 2019 | 6551 | 0.590 |
Why?
|
Medical Subject Headings | 1 | 2017 | 16 | 0.580 |
Why?
|
Biostatistics | 1 | 2019 | 164 | 0.580 |
Why?
|
Humans | 131 | 2024 | 760621 | 0.570 |
Why?
|
Lyme Disease | 1 | 2023 | 630 | 0.560 |
Why?
|
Semen | 1 | 2018 | 346 | 0.530 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 469 | 0.520 |
Why?
|
Fatty Liver | 1 | 2022 | 778 | 0.520 |
Why?
|
Phthalic Acids | 1 | 2021 | 476 | 0.520 |
Why?
|
Bupropion | 1 | 2018 | 304 | 0.520 |
Why?
|
Fertilization | 1 | 2016 | 197 | 0.510 |
Why?
|
Fertility | 2 | 2018 | 773 | 0.510 |
Why?
|
Risk Factors | 31 | 2024 | 74359 | 0.500 |
Why?
|
Sperm Motility | 1 | 2016 | 265 | 0.500 |
Why?
|
Environment | 5 | 2020 | 1118 | 0.490 |
Why?
|
Epidemiologic Methods | 2 | 2021 | 1343 | 0.490 |
Why?
|
Body Height | 1 | 2021 | 1570 | 0.490 |
Why?
|
Epidemiologic Studies | 3 | 2015 | 670 | 0.480 |
Why?
|
Bacteria | 3 | 2022 | 2199 | 0.480 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9411 | 0.470 |
Why?
|
Biomedical Research | 2 | 2022 | 3426 | 0.450 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 998 | 0.450 |
Why?
|
Mortality | 3 | 2024 | 2916 | 0.450 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2013 | 52 | 0.450 |
Why?
|
Cholesterol | 2 | 2020 | 2924 | 0.430 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5889 | 0.430 |
Why?
|
Models, Theoretical | 6 | 2024 | 3562 | 0.420 |
Why?
|
Hyperglycemia | 2 | 2021 | 1380 | 0.420 |
Why?
|
Data Interpretation, Statistical | 3 | 2024 | 2696 | 0.410 |
Why?
|
Phenols | 2 | 2013 | 514 | 0.410 |
Why?
|
Blood | 1 | 2015 | 586 | 0.410 |
Why?
|
Spermatozoa | 1 | 2016 | 631 | 0.410 |
Why?
|
Reproduction | 1 | 2017 | 646 | 0.410 |
Why?
|
Breast Feeding | 1 | 2020 | 1355 | 0.390 |
Why?
|
Genetics, Population | 3 | 2013 | 930 | 0.380 |
Why?
|
Cause of Death | 2 | 2024 | 3725 | 0.380 |
Why?
|
Fasting | 3 | 2024 | 1603 | 0.370 |
Why?
|
Aging | 3 | 2020 | 8651 | 0.370 |
Why?
|
Insulin Resistance | 4 | 2022 | 3959 | 0.370 |
Why?
|
Telomere | 1 | 2017 | 933 | 0.360 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15289 | 0.360 |
Why?
|
Computer Simulation | 6 | 2024 | 6218 | 0.360 |
Why?
|
Exercise | 2 | 2024 | 5787 | 0.350 |
Why?
|
Environmental Monitoring | 4 | 2017 | 1441 | 0.340 |
Why?
|
Communicable Diseases | 1 | 2018 | 878 | 0.340 |
Why?
|
Dementia | 1 | 2024 | 2649 | 0.340 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1447 | 0.330 |
Why?
|
Benzhydryl Compounds | 2 | 2013 | 941 | 0.330 |
Why?
|
Male | 53 | 2024 | 359744 | 0.330 |
Why?
|
Prescription Drugs | 1 | 2016 | 630 | 0.320 |
Why?
|
Risk Assessment | 9 | 2024 | 24123 | 0.320 |
Why?
|
Adult | 39 | 2024 | 219994 | 0.310 |
Why?
|
Sexual Behavior | 1 | 2018 | 2086 | 0.310 |
Why?
|
Socioeconomic Factors | 4 | 2023 | 7806 | 0.310 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4291 | 0.310 |
Why?
|
Female | 50 | 2024 | 391270 | 0.300 |
Why?
|
United States | 20 | 2024 | 72461 | 0.300 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 1091 | 0.290 |
Why?
|
Body Mass Index | 7 | 2022 | 12914 | 0.290 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3775 | 0.280 |
Why?
|
Middle Aged | 32 | 2024 | 220352 | 0.280 |
Why?
|
Occupational Exposure | 1 | 2017 | 1809 | 0.280 |
Why?
|
Maternal Exposure | 1 | 2013 | 1045 | 0.270 |
Why?
|
Cohort Studies | 13 | 2023 | 41335 | 0.270 |
Why?
|
Income | 1 | 2015 | 1875 | 0.260 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7408 | 0.250 |
Why?
|
Public Health | 3 | 2017 | 2653 | 0.250 |
Why?
|
Carotenoids | 3 | 2013 | 620 | 0.240 |
Why?
|
Cross-Sectional Studies | 13 | 2024 | 25942 | 0.240 |
Why?
|
Coronary Disease | 1 | 2019 | 5990 | 0.240 |
Why?
|
Nutrition Policy | 2 | 2019 | 470 | 0.230 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4312 | 0.230 |
Why?
|
Prevalence | 7 | 2024 | 15687 | 0.230 |
Why?
|
Obesity | 4 | 2023 | 12922 | 0.230 |
Why?
|
Reference Values | 3 | 2021 | 4925 | 0.230 |
Why?
|
Young Adult | 17 | 2024 | 58741 | 0.230 |
Why?
|
Multivariate Analysis | 5 | 2018 | 12159 | 0.230 |
Why?
|
Motor Activity | 1 | 2013 | 2687 | 0.220 |
Why?
|
Smoking | 3 | 2023 | 9073 | 0.220 |
Why?
|
Delphi Technique | 2 | 2024 | 829 | 0.220 |
Why?
|
Blood Pressure | 2 | 2016 | 8525 | 0.210 |
Why?
|
Cluster Analysis | 4 | 2021 | 2698 | 0.210 |
Why?
|
Climate | 1 | 2023 | 147 | 0.210 |
Why?
|
Diabetic Nephropathies | 2 | 2024 | 988 | 0.210 |
Why?
|
Linear Models | 3 | 2018 | 5877 | 0.210 |
Why?
|
Chronic Disease | 3 | 2023 | 9287 | 0.200 |
Why?
|
Weather | 1 | 2023 | 226 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2021 | 15789 | 0.200 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11345 | 0.200 |
Why?
|
Health Surveys | 3 | 2020 | 4063 | 0.190 |
Why?
|
Cardiac Imaging Techniques | 1 | 2024 | 269 | 0.190 |
Why?
|
Premature Birth | 1 | 2013 | 1771 | 0.190 |
Why?
|
Health Status | 1 | 2015 | 4081 | 0.190 |
Why?
|
Sample Size | 3 | 2021 | 840 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15757 | 0.190 |
Why?
|
Netherlands | 3 | 2021 | 2213 | 0.190 |
Why?
|
Algorithms | 8 | 2024 | 13981 | 0.190 |
Why?
|
Neoplasms | 6 | 2022 | 22072 | 0.180 |
Why?
|
Lipids | 1 | 2012 | 3336 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2024 | 421 | 0.180 |
Why?
|
Waist Circumference | 2 | 2022 | 926 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6849 | 0.180 |
Why?
|
Asthma | 1 | 2019 | 6172 | 0.180 |
Why?
|
Parabens | 1 | 2021 | 114 | 0.170 |
Why?
|
Databases, Genetic | 3 | 2018 | 1738 | 0.170 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 141 | 0.170 |
Why?
|
Receptors, GABA-A | 1 | 2024 | 621 | 0.170 |
Why?
|
Aged | 18 | 2024 | 169152 | 0.170 |
Why?
|
Drinking Behavior | 1 | 2020 | 103 | 0.170 |
Why?
|
Infant | 9 | 2024 | 36060 | 0.170 |
Why?
|
Pharmacoepidemiology | 1 | 2023 | 350 | 0.170 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.170 |
Why?
|
Micrognathism | 1 | 2019 | 63 | 0.170 |
Why?
|
Psychopathology | 1 | 2022 | 429 | 0.160 |
Why?
|
California | 1 | 2023 | 1416 | 0.160 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1683 | 0.160 |
Why?
|
Meat Products | 1 | 2019 | 96 | 0.160 |
Why?
|
Micronutrients | 2 | 2012 | 381 | 0.160 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2471 | 0.160 |
Why?
|
Coloboma | 1 | 2019 | 59 | 0.160 |
Why?
|
Vibration | 1 | 2021 | 327 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 166 | 0.160 |
Why?
|
Trypsinogen | 1 | 2018 | 84 | 0.160 |
Why?
|
Sex Factors | 3 | 2020 | 10547 | 0.160 |
Why?
|
Genetic Testing | 2 | 2023 | 3531 | 0.160 |
Why?
|
Family Characteristics | 1 | 2024 | 1001 | 0.160 |
Why?
|
Programming, Linear | 1 | 2018 | 8 | 0.160 |
Why?
|
Air Pollution | 2 | 2023 | 2317 | 0.160 |
Why?
|
Delayed Graft Function | 1 | 2018 | 49 | 0.150 |
Why?
|
Hand Deformities, Congenital | 1 | 2019 | 174 | 0.150 |
Why?
|
Age Factors | 3 | 2024 | 18416 | 0.150 |
Why?
|
Life Style | 3 | 2020 | 3896 | 0.150 |
Why?
|
Air Pollutants | 2 | 2023 | 2844 | 0.150 |
Why?
|
Research Design | 4 | 2023 | 6180 | 0.150 |
Why?
|
Trypsin | 1 | 2018 | 496 | 0.150 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1006 | 0.150 |
Why?
|
Geography | 1 | 2020 | 661 | 0.150 |
Why?
|
Adolescent | 13 | 2024 | 87810 | 0.150 |
Why?
|
Prospective Studies | 8 | 2021 | 54303 | 0.150 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 724 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2022 | 2421 | 0.150 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11847 | 0.150 |
Why?
|
Twins | 1 | 2019 | 339 | 0.140 |
Why?
|
Nervous System Malformations | 1 | 2019 | 244 | 0.140 |
Why?
|
Cadmium | 2 | 2020 | 215 | 0.140 |
Why?
|
Asparaginase | 1 | 2018 | 240 | 0.140 |
Why?
|
MEDLINE | 1 | 2017 | 119 | 0.140 |
Why?
|
Mifepristone | 1 | 2018 | 150 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 488 | 0.140 |
Why?
|
Embolism, Fat | 1 | 2017 | 46 | 0.140 |
Why?
|
Self Report | 2 | 2020 | 3711 | 0.140 |
Why?
|
RNA Splicing | 1 | 2021 | 915 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2418 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1207 | 0.140 |
Why?
|
T-Box Domain Proteins | 1 | 2019 | 468 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2221 | 0.140 |
Why?
|
Alleles | 4 | 2024 | 6898 | 0.140 |
Why?
|
Specialization | 1 | 2021 | 778 | 0.140 |
Why?
|
Epilepsy | 2 | 2024 | 3267 | 0.140 |
Why?
|
Donor Selection | 1 | 2018 | 228 | 0.140 |
Why?
|
Fumarates | 1 | 2017 | 131 | 0.130 |
Why?
|
Child, Preschool | 9 | 2024 | 42063 | 0.130 |
Why?
|
Hypertension | 1 | 2016 | 8594 | 0.130 |
Why?
|
Diet | 4 | 2019 | 8010 | 0.130 |
Why?
|
Sperm Count | 1 | 2016 | 228 | 0.130 |
Why?
|
Coffee | 1 | 2020 | 582 | 0.130 |
Why?
|
Thyroid Nodule | 1 | 2023 | 760 | 0.130 |
Why?
|
Pandemics | 3 | 2024 | 8624 | 0.130 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.130 |
Why?
|
Pregnancy, Ectopic | 1 | 2017 | 143 | 0.130 |
Why?
|
Feces | 1 | 2022 | 1455 | 0.130 |
Why?
|
Insurance, Health | 2 | 2019 | 2501 | 0.130 |
Why?
|
Body Dysmorphic Disorders | 1 | 2019 | 243 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1231 | 0.130 |
Why?
|
Population Groups | 1 | 2016 | 211 | 0.120 |
Why?
|
Pancreas | 1 | 2022 | 1677 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1268 | 0.120 |
Why?
|
Oligonucleotide Probes | 1 | 2015 | 418 | 0.120 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 516 | 0.120 |
Why?
|
Fibrosis | 1 | 2022 | 2042 | 0.120 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2015 | 25 | 0.120 |
Why?
|
Renal Dialysis | 1 | 2024 | 1801 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 786 | 0.120 |
Why?
|
Australia | 3 | 2024 | 1289 | 0.120 |
Why?
|
Neck | 1 | 2019 | 731 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2061 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3113 | 0.120 |
Why?
|
Amides | 1 | 2017 | 448 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2192 | 0.120 |
Why?
|
beta Catenin | 1 | 2019 | 1043 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 459 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2775 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1343 | 0.110 |
Why?
|
Selection, Genetic | 1 | 2018 | 869 | 0.110 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12531 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 374 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2016 | 727 | 0.110 |
Why?
|
Face | 1 | 2019 | 1017 | 0.110 |
Why?
|
Triclosan | 1 | 2013 | 58 | 0.110 |
Why?
|
Homosexuality, Female | 1 | 2015 | 159 | 0.110 |
Why?
|
India | 1 | 2020 | 2336 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 749 | 0.110 |
Why?
|
Bisexuality | 1 | 2015 | 274 | 0.110 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2180 | 0.110 |
Why?
|
Models, Genetic | 3 | 2017 | 3442 | 0.110 |
Why?
|
Child | 11 | 2024 | 79806 | 0.110 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6853 | 0.110 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1189 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1347 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2024 | 26181 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2021 | 2197 | 0.100 |
Why?
|
Pesticides | 2 | 2018 | 293 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.100 |
Why?
|
Ecosystem | 1 | 2016 | 485 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14495 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2019 | 1415 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2018 | 2362 | 0.100 |
Why?
|
Cerebellum | 1 | 2019 | 1496 | 0.100 |
Why?
|
Virulence | 1 | 2016 | 1298 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2097 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2764 | 0.100 |
Why?
|
RNA | 1 | 2021 | 2722 | 0.100 |
Why?
|
HIV Infections | 1 | 2018 | 17165 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2024 | 80372 | 0.100 |
Why?
|
Pancreatitis | 1 | 2018 | 1100 | 0.100 |
Why?
|
Pregnancy | 4 | 2018 | 29749 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1931 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 487 | 0.100 |
Why?
|
Nutritional Status | 3 | 2017 | 1607 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20080 | 0.090 |
Why?
|
Vitamin E | 1 | 2015 | 872 | 0.090 |
Why?
|
Electronic Health Records | 3 | 2023 | 4775 | 0.090 |
Why?
|
gamma-Tocopherol | 1 | 2010 | 30 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1504 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 21392 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2250 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2061 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11903 | 0.090 |
Why?
|
Emigration and Immigration | 1 | 2013 | 395 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 944 | 0.090 |
Why?
|
Genotype | 4 | 2024 | 12960 | 0.090 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 452 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 29658 | 0.080 |
Why?
|
Medication Adherence | 1 | 2021 | 2165 | 0.080 |
Why?
|
Gene Frequency | 2 | 2016 | 3615 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1547 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3334 | 0.080 |
Why?
|
Hazardous Substances | 1 | 2010 | 152 | 0.080 |
Why?
|
Genomics | 3 | 2022 | 5794 | 0.080 |
Why?
|
Proteins | 1 | 2024 | 6029 | 0.080 |
Why?
|
Glioma | 1 | 2024 | 3420 | 0.080 |
Why?
|
Glucose | 1 | 2021 | 4351 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2313 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9631 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2026 | 0.080 |
Why?
|
Kidney Calculi | 1 | 2013 | 468 | 0.080 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 235 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4611 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58995 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3213 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5066 | 0.070 |
Why?
|
Dietary Fats | 1 | 2015 | 1992 | 0.070 |
Why?
|
Fatty Acids | 1 | 2015 | 1804 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2023 | 2326 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2709 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3204 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3455 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13630 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1535 | 0.070 |
Why?
|
Potassium, Dietary | 2 | 2020 | 104 | 0.070 |
Why?
|
Feeding Behavior | 2 | 2015 | 3185 | 0.070 |
Why?
|
Adiposity | 1 | 2016 | 1858 | 0.070 |
Why?
|
Liver | 1 | 2022 | 7509 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3218 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 1817 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1357 | 0.060 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2005 | 56 | 0.060 |
Why?
|
Health Promotion | 1 | 2017 | 2206 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4426 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 8950 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3839 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.060 |
Why?
|
Chorioallantoic Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3150 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3315 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 773 | 0.060 |
Why?
|
Veterans Disability Claims | 1 | 2024 | 24 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10344 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2476 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7588 | 0.060 |
Why?
|
Medicaid | 1 | 2017 | 2815 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4215 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 29932 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11891 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1932 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8986 | 0.050 |
Why?
|
Spin Labels | 1 | 2024 | 336 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2420 | 0.050 |
Why?
|
Odds Ratio | 3 | 2024 | 9716 | 0.050 |
Why?
|
Family | 2 | 2015 | 3189 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9962 | 0.050 |
Why?
|
Databases, Protein | 1 | 2024 | 388 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4878 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1403 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8547 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1500 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3164 | 0.050 |
Why?
|
Spirometry | 1 | 2024 | 924 | 0.050 |
Why?
|
Chemokine CCL22 | 1 | 2020 | 27 | 0.050 |
Why?
|
Clinical Chemistry Tests | 1 | 2020 | 59 | 0.050 |
Why?
|
Financing, Government | 1 | 2024 | 472 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 238 | 0.040 |
Why?
|
Blindness | 1 | 2024 | 582 | 0.040 |
Why?
|
gamma-Glutamyltransferase | 1 | 2020 | 144 | 0.040 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2020 | 81 | 0.040 |
Why?
|
Ethics, Research | 1 | 2021 | 176 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2020 | 234 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4360 | 0.040 |
Why?
|
American Heart Association | 1 | 2024 | 1081 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 2019 | 111 | 0.040 |
Why?
|
Conflict of Interest | 1 | 2024 | 549 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1376 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 195 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8515 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5508 | 0.040 |
Why?
|
England | 1 | 2020 | 526 | 0.040 |
Why?
|
Computer Communication Networks | 1 | 2020 | 294 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15840 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 742 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2019 | 155 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 438 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36290 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2023 | 770 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 718 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2475 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 1336 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 865 | 0.040 |
Why?
|
Triolein | 1 | 2017 | 9 | 0.040 |
Why?
|
Serum Albumin | 1 | 2020 | 674 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1082 | 0.040 |
Why?
|
National Health Programs | 1 | 2020 | 441 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1826 | 0.030 |
Why?
|
Mouth | 1 | 2019 | 380 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2021 | 653 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1600 | 0.030 |
Why?
|
Magnesium | 1 | 2020 | 810 | 0.030 |
Why?
|
Biodiversity | 1 | 2019 | 345 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2017 | 221 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1724 | 0.030 |
Why?
|
Logistic Models | 2 | 2024 | 13314 | 0.030 |
Why?
|
Multigene Family | 1 | 2019 | 1077 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 754 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2024 | 1486 | 0.030 |
Why?
|
Caffeine | 1 | 2020 | 702 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5351 | 0.030 |
Why?
|
Microcephaly | 1 | 2019 | 425 | 0.030 |
Why?
|
Brain Death | 1 | 2018 | 356 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1903 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2024 | 1305 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2016 | 21025 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1223 | 0.030 |
Why?
|
Lead | 1 | 2020 | 880 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2019 | 1135 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1915 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2733 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.030 |
Why?
|
Schools | 1 | 2022 | 1480 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4035 | 0.030 |
Why?
|
Diet Records | 1 | 2015 | 427 | 0.030 |
Why?
|
Folic Acid | 1 | 2020 | 1309 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 982 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 2005 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 830 | 0.030 |
Why?
|
Human Genome Project | 1 | 2013 | 199 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3441 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4490 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2022 | 2062 | 0.030 |
Why?
|
Vitiligo | 1 | 2013 | 98 | 0.030 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2013 | 88 | 0.030 |
Why?
|
Peptides | 1 | 2024 | 4354 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1717 | 0.020 |
Why?
|
Vitamins | 1 | 2020 | 1634 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5305 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4107 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2020 | 2529 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2893 | 0.020 |
Why?
|
Alopecia Areata | 1 | 2013 | 127 | 0.020 |
Why?
|
Vitamin B Complex | 1 | 2012 | 297 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13262 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9467 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1710 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1832 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2559 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10551 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2015 | 726 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 5961 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5201 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1902 | 0.020 |
Why?
|
Scleroderma, Systemic | 1 | 2013 | 344 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2012 | 425 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1570 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3364 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3794 | 0.020 |
Why?
|
Minority Groups | 1 | 2015 | 1201 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13451 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12808 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4578 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8469 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6360 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4713 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8158 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11071 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3616 | 0.020 |
Why?
|
Energy Intake | 1 | 2012 | 2129 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2932 | 0.010 |
Why?
|
Chick Embryo | 1 | 2005 | 981 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3986 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23376 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16939 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2013 | 1919 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23711 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2013 | 2159 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2819 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2276 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4013 | 0.010 |
Why?
|
Animals | 3 | 2019 | 167963 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6597 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40165 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18137 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5781 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39261 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2448 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15697 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12446 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12766 | 0.010 |
Why?
|